Skip to main content
Signal8

Radhakrishnan Karthik

SEC insider (Form 3/4/5 filer). CIK 0001573327. Chief Financial Officer at Monopar Therapeutics (MNPR). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 28, 2024. Located in WILMETTE, IL.

Companies Radhakrishnan Karthik has filed insider reports for

  • Monopar Therapeutics (MNPR): Officer, Chief Financial Officer
Radhakrishnan Karthik profile photo

Radhakrishnan Karthik

CIK: 0001573327

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monopar Therapeutics logo
MNPR

Monopar Therapeutics

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Oct 28, 2024
    Purchase
    Direct
    1.6K shares at avg. $16.25$25K

1-1 of 1